Long-term persistence of neutralizing SARS-CoV-2 antibodies in pets

被引:31
|
作者
Decaro, Nicola [1 ]
Grassi, Andrea [2 ]
Lorusso, Eleonora [1 ]
Patterson, Edward, I [3 ]
Lorusso, Alessio [4 ]
Desario, Costantina [1 ]
Anderson, Enyia R. [5 ]
Vasinioti, Violetta [1 ]
Wastika, Christida E. [5 ]
Hughes, Grant L. [5 ]
Valleriani, Fabrizia [4 ]
Colitti, Barbara [6 ]
Ricci, Dominga [7 ]
Buonavoglia, Domenico [1 ]
Rosati, Sergio [6 ]
Cavaliere, Nicola [8 ]
Paltrinieri, Saverio [9 ]
Lauzi, Stefania [9 ]
Elia, Gabriella [1 ]
Buonavoglia, Canio [1 ]
机构
[1] Univ Bari, Dept Vet Med, Valenzano, Italy
[2] I VET Srl, Lab Anal Vet, Flero, Italy
[3] Brock Univ, Dept Biol Sci, St Catharines, ON, Canada
[4] Ist Zooprofilatt Sperimentale Abruzzo & Molise G, Teramo, Italy
[5] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England
[6] Ambulatorio Vet Ricci Dottssa Dominga, Andria, Italy
[7] Univ Turin, Dept Vet Sci, Turin, Italy
[8] Ist Zooprofilatt Sperimentale Puglia & Basilicata, Foggia, Italy
[9] Univ Milan, Dept Vet Med, Lodi, Italy
基金
欧盟地平线“2020”;
关键词
cat; dog; ELISA; long-term persistence; plaque reduction neutralization test; SARS-CoV-2; antibodies; virus neutralization;
D O I
10.1111/tbed.14308
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
We monitored the severe acute respiratory syndrome coronavirus 2 antibody response in seven dogs and two cats by using two multispecies ELISA tests, plaque reduction neutralisation test and virus neutralization. SARS-CoV-2 neutralizing antibodies in pets persisted up to 10 months since the first positive testing, thus replicating observations in COVID-19 human patients.
引用
收藏
页码:3073 / 3076
页数:4
相关论文
共 50 条
  • [31] A quantitative assay for detection of SARS-CoV-2 neutralizing antibodies
    Cerutti, Helena
    Bandini, Tommaso
    Castria, Marinunzia
    Cartocci, Alessandra
    Ricci, Veronica
    Tornesi, Stefania
    Bogi, Alessia
    Tesi, Giulia
    Soldatini, Claudia
    Toppi, Simona
    Brogi, Alessandra
    JOURNAL OF CLINICAL VIROLOGY, 2022, 147
  • [32] Human neutralizing antibodies for SARS-CoV-2 prevention and immunotherapy
    Zhou, Dongyan
    Zhou, Runhong
    Chen, Zhiwei
    IMMUNOTHERAPY ADVANCES, 2022, 2 (01):
  • [33] Human neutralizing antibodies elicited by SARS-CoV-2 infection
    Ju, Bin
    Zhang, Qi
    Ge, Jiwan
    Wang, Ruoke
    Sun, Jing
    Ge, Xiangyang
    Yu, Jiazhen
    Shan, Sisi
    Zhou, Bing
    Song, Shuo
    Tang, Xian
    Yu, Jinfang
    Lan, Jun
    Yuan, Jing
    Wang, Haiyan
    Zhao, Juanjuan
    Zhang, Shuye
    Wang, Youchun
    Shi, Xuanling
    Liu, Lei
    Zhao, Jincun
    Wang, Xinquan
    Zhang, Zheng
    Zhang, Linqi
    NATURE, 2020, 584 (7819) : 115 - +
  • [34] Pan-neutralizing, germline-encoded antibodies against SARS-CoV-2: Addressing the long-term problem of escape variants
    Lunderberg, Justin Mark
    Dutta, Sanjucta
    Collier, Ai-Ris Y.
    Lee, Jeng-Shin
    Hsu, Yen-Ming
    Wang, Qiao
    Zheng, Weina
    Hao, Shushun
    Zhang, Haohai
    Feng, Lili
    Robson, Simon C.
    Gao, Wenda
    Riedel, Stefan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [35] Neutralizing antibodies targeting SARS-CoV-2 spike protein
    Shi Xiaojie
    Li Yu
    Yan Lei
    Yang Guang
    Qiang Min
    STEM CELL RESEARCH, 2021, 50
  • [36] Long-term persistence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein-specific and neutralizing antibodies in recovered COVID-19 patients
    Chansaenroj, Jira
    Yorsaeng, Ritthideach
    Puenpa, Jiratchaya
    Wanlapakorn, Nasamon
    Chirathaworn, Chintana
    Sudhinaraset, Natthinee
    Sripramote, Manit
    Chalongviriyalert, Piti
    Jirajariyavej, Supunee
    Kiatpanabhikul, Phatharaporn
    Saiyarin, Jatuporn
    Soudon, Chulikorn
    Thienfaidee, Orawan
    Ayuthaya, Thitisan Palakawong Na
    Brukesawan, Chantapat
    Intharasongkroh, Duangnapa
    Chaiwanichsiri, Dootchai
    Issarasongkhram, Mila
    Kitphati, Rungrueng
    Mungaomklang, Anek
    Thitithanyanont, Arunee
    Nagavajara, Pijaya
    Poovorawan, Yong
    PLOS ONE, 2022, 17 (04):
  • [37] Duration of SARS-CoV-2 Serum-Neutralizing Antibodies Against SARS-CoV-2 Dependent on the Individual
    Li, Jin
    Zou, Li
    Li, Shaojie
    Zou, Ruogu
    Fang, Zhixiong
    Zhang, Pingan
    Li, Huijun
    Wang, Shanshan
    Ke, Dong
    Gao, Peng
    Jin, Cuicui
    Fang, Cong
    Zhou, Ji
    He, Ellen
    Skog, Sven
    VIRAL IMMUNOLOGY, 2023, 36 (03) : 153 - 162
  • [38] Persistence of the neutralizing antibody response after SARS-CoV-2 infection
    Shim, Sang-Mu
    Kim, Jun-Won
    Jung, Sunhee
    Jung, Yujung
    Woo, Hye-Min
    Yang, Jeong-Sun
    Kim, Kyung-Chang
    Lee, Joo-Yeon
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (04) : 614.e1 - 614.e4
  • [39] Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers
    Huynen, Pascale
    Gregoire, Celine
    Gofflot, Stephanie
    Seidel, Laurence
    Maes, Nathalie
    Vranken, Laura
    Delcour, Sandra
    Moutschen, Michel
    Hayette, Marie-Pierre
    Kolh, Philippe
    Melin, Pierrette
    Beguin, Yves
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [40] Long-term longitudinal evaluation of the prevalence of SARS-CoV-2 antibodies in healthcare and university workers
    Pascale Huynen
    Céline Grégoire
    Stéphanie Gofflot
    Laurence Seidel
    Nathalie Maes
    Laura Vranken
    Sandra Delcour
    Michel Moutschen
    Marie-Pierre Hayette
    Philippe Kolh
    Pierrette Melin
    Yves Beguin
    Scientific Reports, 12